Literature DB >> 6421110

Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism.

P A LeWitt, L P Miller, R P Newman, R S Burns, T Insel, R A Levine, W Lovenberg, D B Calne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421110

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  7 in total

1.  Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

Authors:  R J Mandel; K G Rendahl; S K Spratt; R O Snyder; L K Cohen; S E Leff
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

2.  The effect of age on tetrahydrobiopterin metabolism in the human brain.

Authors:  J Anderson; J A Blair; R A Armstrong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

3.  Plasma and urinary levels of biopterin, neopterin, and related pterins and plasma levels of folate in infantile autism.

Authors:  I Eto; M D Bandy; C E Butterworth
Journal:  J Autism Dev Disord       Date:  1992-06

4.  Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease.

Authors:  O Corti; A Sánchez-Capelo; P Colin; N Hanoun; M Hamon; J Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 5.  Is NADH effective in the treatment of Parkinson's disease?

Authors:  R H Swerdlow
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

6.  Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.

Authors:  W Jung; H Herken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

Review 7.  What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?

Authors:  David A Loeffler; Jan O Aasly; Peter A LeWitt; Mary P Coffey
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.